Investigating National Solutions for Personalised Iodine-131 Radiation Exposure

NCT04391244 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2023-08-18

No results posted yet for this study

Summary

This is a single-arm non-interventional prospective observational study to perform quantitative I-131 imaging and patient-specific dosimetry for patients undergoing radioiodine treatment.

Conditions

  • Differentiated Thyroid Cancer

Sponsors & Collaborators

  • Royal Marsden NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Kate Newbold · Consultant Clinical Oncologist

  • Glenn Flux · Head of Radioisotope Physics

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-17
Primary Completion
2024-03-31
Completion
2025-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04391244 on ClinicalTrials.gov